The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease

Abstract East Asian patients have reduced anti-ischemic benefits and increased bleeding risk during antithrombotic therapies compared with Caucasian patients. As potent P2Y 12 receptor inhibitors (e.g., ticagrelor and prasugrel) and direct oral anticoagulants are commonly used in current daily pract...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Thrombosis and haemostasis Jg. 121; H. 4; S. 422 - 432
Hauptverfasser:	Kim, Hyun Kuk, Tantry, Udaya S., Smith, Sidney C., Jeong, Myung Ho, Park, Seung-Jung, Kim, Moo Hyun, Lim, Do-Sun, Shin, Eun-Seok, Park, Duk-Woo, Huo, Yong, Chen, Shao-Liang, Bo, Zheng, Goto, Shinya, Kimura, Takeshi, Yasuda, Satoshi, Chen, Wen-Jone, Chan, Mark, Aradi, Daniel, Geisler, Tobias, Gorog, Diana A., Sibbing, Dirk, Lip, Gregory Y. H., Angiolillo, Dominick J., Gurbel, Paul A., Jeong, Young-Hoon
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Rüdigerstraße 14, 70469 Stuttgart, Germany Georg Thieme Verlag KG 01.04.2021
Schlagworte:	Review Article direct oral anticoagulants bleeding risk antiplatelet therapy race ischemic risk
ISSN:	0340-6245, 2567-689X, 2567-689X
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!